[Recent advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention].
No-reflow is defined as a failure to restore antegrade normal coronary flow, despite appropriate treatment of coronary obstruction. This phenomenon occurs in 5% to 50% of patients undergoing percutaneous coronary intervention, depending on the methods used to assess it and the clinical scenario. This article reviews recent advances in understanding the aspects of no-reflow and provides details on the current knowledge and future developments in diagnosis, prevention and treatment of this complication.
Capodanno
Davide
D
Dipartimento di Cardiologia, Ospedale Ferrarotto, Università, Catania.
Tamburino
Corrado
C
D000241:Adenosine / Q000627:therapeutic use; D000322:Adrenergic Agonists / Q000627:therapeutic use; D000367:Age Factors; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D017023:Coronary Angiography; D003326:Coronary Circulation; D004837:Epinephrine / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D012307:Risk Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
D000322:Adrenergic Agonists; D014665:Vasodilator Agents; D000241:Adenosine; D004837:Epinephrine